Case Reports
doi: 10.1016/j.farma.2009.09.009.
Epub 2010 Jan 22.
[Dabigatran in the treatment of a morbidly obese patient with recurring venous thrombosis]
[Article in
Spanish]
- PMID: 20304372
- DOI: 10.1016/j.farma.2009.09.009
Item in Clipboard
Case Reports
[Dabigatran in the treatment of a morbidly obese patient with recurring venous thrombosis]
[Article in
Spanish]
Farm Hosp.
2010 Mar-Apr.
Free article
No abstract available
Comment on
-
[Pharmacokinetics and pharmacodynamics of the new oral anticoagulants dabigatran and rivaroxaban].Farm Hosp. 2009 May-Jun;33(3):125-33. Farm Hosp. 2009. PMID: 19712596 Spanish.
Similar articles
-
Dabigatran: new drug. Continue to use heparin, a better-known option.Prescrire Int. 2009 Jun;18(101):97-9. Prescrire Int. 2009. PMID: 19637411
-
Dabigatran offers the simplest solution for thromboprophylaxis after orthopaedic surgery in patients allergic to low-molecular-weight heparins.Br J Haematol. 2010 Oct;151(1):84-5. doi: 10.1111/j.1365-2141.2010.08290.x. Epub 2010 Jul 7. Br J Haematol. 2010. PMID: 20618326 No abstract available.
-
Beyond unfractionated heparin and warfarin: current and future advances.Circulation. 2007 Jul 31;116(5):552-60. doi: 10.1161/CIRCULATIONAHA.106.685974. Circulation. 2007. PMID: 17664384 Review. No abstract available.
-
Direct thrombin inhibitors.N Engl J Med. 2005 Sep 8;353(10):1028-40. doi: 10.1056/NEJMra044440. N Engl J Med. 2005. PMID: 16148288 No abstract available.
-
Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux.Int Angiol. 2011 Jun;30(3):199-211. Int Angiol. 2011. PMID: 21617603 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
